Search
for
Sort by
Research 61–90 of 1000+
- Current and Emerging Approaches to Androgenetic Alopecia
- 195 Androgen action and 3D culture conditions influence dermal papilla cells inductive properties: the role of Wnt agonists/antagonists balance
- Discriminating in favour of or against men with increased risk of finasteride-related side effects?
- ANTI-ALOPECIA ACTIVITY OF MORINGA (MORINGA OLEIFERA LAMK.) SEED OIL AGAINST DIHYDROTESTOSTERONE-INDUCED RABBITS
- In Vivo Time-Dependent Inhibition of Human Steroid 5a-Reductase by Finasteride
- Altered brain and pituitary androgen metabolism by prenatal, perinatal or pre- and postnatal finasteride, flutamide or dihydrotestosterone treatment in juvenile male rats
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Pathogenesis of androgenetic alopecia
- Effect of finasteride on the ovulatory function of normal women
- Finasteride: A slow-binding 5.alpha.-reductase inhibitor
- ANDROGENETIC ALOPECIA: A REVIEW OF CURRENT THERAPEUTIC OPTIONS
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- 5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers
- C<sub>19</sub>and C<sub>21</sub>5<i>β</i>/5<i>α</i>Metabolite Ratios in Subjects Treated with the 5<i>α</i>-Reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5<i>α</i>-Reductase Deficiency*
- Male Pattern Baldness
- Finasteride
- DUTASTERIDE AS AN EFFECTIVE TREATMENT IN ANDROGENETIC ALOPECIA – A LITERATURE REVIEW
- Identification of a Rare Variant in the <i>SRD5A2</i> Gene in Siblings With 46,XY Disorders of Sexual Development
- Theoretical Evaluation of Twenty-Cannabinoid Derivatives on Either Androgen Receptor or 5α-Reductase Enzyme
- Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive human hair dermal papilla cell-based assay
- Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content*
- Testosterone’s regulation of the HPA axis differs for adolescent and adult male rats
- Hair characteristics and androgenetic alopecia in Koreans
- Dutasteride
- Effect of 5α-Dihydrotestosterone and Testosterone on Apoptosis in Human Dermal Papilla Cells
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.